Positive outcomes include improved understanding of MPS and fibromyalgia, potential for effective treatment through movement and mechanical interventions, and the suggestion that a new treatment approach may enhance recovery from these conditions.
PNE has been shown to produce clinically significant reductions in pain catastrophizing and kinesiophobia, leading to improvements in pain and disability in the short and medium term.
The expected positive outcomes include improved pain management, enhanced functional capacity, better quality of life, and reduced symptoms of fibromyalgia, as evidenced by previous studies on exercise interventions.
Cannabinoids have shown efficacy in managing chronic pain, improving quality of life, and reducing opioid use, thereby mitigating the risks associated with opioid dependence.
The systematic review indicates that medical cannabis is a safe and effective treatment option for fibromyalgia, showing improvements in pain management and quality of life for patients.
59% of patients experienced a reduction in the use of opioids, gabapentinoids, or benzodiazepines, with 39% achieving complete cessation of an analgesic agent. The study indicated that sub-lingual ketamine is a safe and effective analgesic for chronic non-malignant pain management.
The expected positive outcomes include reduced pain levels, improved BDNF concentrations, enhanced understanding of pain mechanisms, and overall better management of chronic pain through non-pharmacological means.
Significant clinical improvements in pain management were observed in the CBT group, with increased WM complexity in specific brain regions associated with cognitive and emotional processing of pain.
The intervention resulted in immediate pain and stiffness reduction, sustained pain relief over 14 days, and improved recovery perception compared to placebo.
The study found decreased connectivity within the pain network and changes in connectivity among the default mode, frontoparietal, and salience networks after the ACT intervention, suggesting a reduction in chronic pain perception and improved psychological flexibility.
Two out of four patients exhibited a higher pain threshold with stimulation compared to without, indicating a positive response to the treatment. The study suggests that personalized evaluation of neural activity can help predict the effectiveness of DBS in managing chronic pain.
Mindfulness facets, particularly Acting with Awareness, significantly reduce negative affect and are associated with lower levels of obsession and compulsion in patients with chronic pain.
All studies reported statistically significant improvements in pain levels within intervention groups, indicating that visual arts can effectively reduce the perception of pain and improve psychosocial factors related to pain management.
The study found that the timing of the maximal pain ratings during TS and adaptation was linked to fibromyalgia diagnosis, indicating a unique pain processing pattern in these patients.
Positive outcomes may include reduced kinesiophobia, improved physical function, decreased pain levels, and enhanced quality of life for patients with chronic musculoskeletal pain.